• Compare the advantages/disadvantages of different imaging modalities of the breast including advances in imaging with the incorporation of artificial intelligence.
• Identify different surgical approaches to patients with benign and malignant breast lesions.
• Identify evolving chemotherapy regimens available, including clinical trials, for women with breast cancer.
• Review advances in breast radiation techniques (such as GRID radiotherapy) and the integration of AI in the radiation oncology clinic workflow.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies:
Judy Boughey, M.D. - Honoraria - CairnSurgical Inc.; OncLive; Intellectual Property - MediView XR, Inc.; SimBioSys, Inc.; Presentation Non-CME - EndoMag

Karthik Giridhar, M.D. - Honoraria - AstraZeneca Pharmaceuticals LP; Clinical Care Solutions; Eli Lilly and Company; Exact Sciences Corporation; Gilead Sciences, Inc.; GRAIL, Inc.; MJH Life Sciences, NeoGenomics Laboratories; Novartis Pharma AG; Novartis Pharmaceuticals Corporation; Puma Biotechnology; TerSera Therapeutics, LLC

Aparna Vijayasekaran, M.B.B.S. - Honoraria - Intuitive Surgical Operations, Inc.; Intellectual Property - Melodi Health Inc.

All relevant financial relationships have been mitigated. 

No relevant financial relationship(s) with ineligible companies:

May Elbanna, M.B., B.Ch., Ph.D.
Robert Fazzio, M.D., Ph.D.
Aparna Kaur, M.D.
Christine Klassen, M.D.
Dean Shumway, M.D.
Malvika Solanki, M.B.B.S., Ph.D.
Shannon Zingula, M.D.
Debra Blomberg, M.B.A. (Coordinator)
Sheila Terrill (Coordinator)

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

QUESTIONS?
Contact Sheila Terrill at phone (79)2-5140